Tg Therapeutics, Inc.
TGTX
Revenue
108.19M
▲24.31M▲28.98%
3 Months ChangeAssets
577.69M
▼-8.32M▼-1.42%
3 Months ChangeLiabilities
355.33M
▼-38.53M▼-9.78%
3 Months ChangeFree Cash Flow
-68.70M
▲12.73M▲15.63%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-09
Form 10-Q
ID: 0001437749-24-025853
2024-08-06
Form 8-K
ID: 0001437749-24-024718
2024-06-17
Form 8-K
ID: 0001437749-24-020510
2024-05-06
Form 10-Q
ID: 0001437749-24-014849
2024-05-01
Form 8-K
ID: 0001437749-24-014062
2024-02-28
Form 8-K
ID: 0001437749-24-005802
2024-01-10
Form 8-K
ID: 0001437749-24-001061
2023-11-06
Form 10-Q
ID: 0001437749-23-030412
2023-11-01
Form 8-K
ID: 0001437749-23-029660
2023-08-04
Form 10-Q
ID: 0001558370-23-013429